Who Paid My Doc
Laura Sperazza
Optometrist, Low Vision Rehabilitation Somerset, NJ Doctor of Optometry
NPI 1639210701 CMS profile 209619
1760 Easton Ave, Somerset, NJ 08873
General payments
$128
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Laura Sperazza of Somerset, NJ is reported in the CMS Open Payments database as having received $128 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 34th percentile of Optometrist, Low Vision Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $128 | 2 |
Beside peers
- Laura Sperazza
- Optometrist, Low Vision Rehabilitation median
- Middle half of Optometrist, Low Vision Rehabilitation
- National median
In program year 2025, general payments to Laura Sperazza were reported at $0. Among 89 Optometrist, Low Vision Rehabilitation profiles paid that year, the median was $150 and the middle half received between $50 and $382.
Show as a table
| Year | Laura Sperazza | Optometrist, Low Vision Rehabilitation median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $128 | $126 | $62–$303 | $163 |
| 2020 | $0 | $57 | $19–$124 | $114 |
| 2021 | $0 | $137 | $48–$277 | $132 |
| 2022 | $0 | $135 | $53–$282 | $149 |
| 2023 | $0 | $141 | $52–$361 | $160 |
| 2024 | $0 | $146 | $75–$336 | $164 |
| 2025 | $0 | $150 | $50–$382 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$20,601
Medicare patients
144
Services billed
206
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 58% | |
| Ischemic heart disease | 36% | |
| Diabetes | 33% | |
| Depression | 26% | |
| Osteoporosis | 26% | |
| Chronic kidney disease | 24% | |
| Heart failure | 20% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Low Vision Rehabilitation in New Jersey
Maria Richman
Optometrist, Low Vision Rehabilitation · Manasquan, NJ
Ronald Siwoff
Optometrist, Low Vision Rehabilitation · Denville, NJ
Jeff Schaeffer
Optometrist, Low Vision Rehabilitation · Perth Amboy, NJ
Fazaluddin Hashmi
Optometrist, Low Vision Rehabilitation · Linden, NJ
Vincent Vicci
Optometrist, Low Vision Rehabilitation · Westfield, NJ
Janis White
Optometrist, Low Vision Rehabilitation · East Orange, NJ
Related records
Optometrist, Low Vision Rehabilitation in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Low Vision Rehabilitation
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.